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BACKGROUND As life span increase, the average age of patients un-
dergoing percutaneous coronary intervention (PCI) is increasing.
However, the predictors for adverse clinical outcomes after PCI in
very old age are uncertain in the drug-eluting stent (DES) era.
METHODS A total 3747 patients (pts) underwent PCI from Oct 2004 to
Apr 2013 from prospective PCI registry were evaluated. Inclusion
criteria was octogenarian pts underwent PCI. Exclusion criteria were
in-hospital death and clinical follow-up loss less than 1-year after PCI.
The deﬁnition of ALL-major adverse cardiovascular events (MACEs)
was the composite of total death, any myocardial infarction, and any
revascularization. A total 170 consecutive pts were enrolled.
RESULTS The incidence of ALL-MACE was 24 of 170 (14.1%) pts. At
baseline, gender, ST-segment myocardial infarction, cardiogenic
shock, hypertension, diabetes, dyslipidemia, cerebrovascular acci-
dent, peripheral arterial disease, currents mocking, drugs such as
statin, cilostazol, beta blocker, calcium channel blocker, renin angio-
tensin system blocker, and proton pump inhibitors, multi vessel dis-
ease, hemoglobin level was balanced between ALL-MACE group and
no ALL-MACE group. On the other hands, higher incidence of chronic
kidney disease, older age, and higher baseline creatinine level were
found in ALL-MACE group. In multivariate logistic regression
adjusted by gender, age, chronic kidney disease, ST-elevation
myocardial infarction (STEMI), cardiogenic shock, hypertension, dia-
betes, dyslipidemia, cerebrovascular accident, current smoking, he-
moglobin, cilostazol use, and multi vessel disease, independent
predictors associated with ALL-MACE were age and chronic kidney
disease (Table).
CONCLUSION In our study, age and chronic kidney disease were
closely associated with ALL- MACE during 1-year follow-up in octo-
genarian pts after PCI.
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BACKGROUND Cardiovascular disease (CVD) is frequently associated
with CKD, which is important because individuals with CKD are more
likely to die of CVD than due to kidney disease. CVD in CKD is treat-
able and potentially preventable, and CKD appears to be a risk factor
for CVD. This study aims at evaluating the incidence of vascular
complications in patients with CKD.
METHODS We retrospectively analyzed CAD patients who underwent
PCI, for the effect of eGFR on the vascular complication, in our
institution in 2013. CKD is deﬁned as eGFR <60 ml/min/m2 according
to Cockgrauft gault formula. Vascular complications include hema-
toma, pseudoaneurysm, arteriovenous ﬁstula, arterial occlusion,
retroperitoneal hemorrhage.
RESULTS 950 patients who underwent percutaneous coronary inter-
vention (PCI) procedures were classiﬁed into CKD group (n¼380,40%)
and non-CKD groups(n¼570,60%).We analyzed the occurrence of post
PCI vascular complications in these two groups. Demographic details
were given in the table.CKD mean(SD) Non-CKD mean(SD) P valueAge (years) 57.2(10.7) 54.1(10) 0BMI (kg/m2) 23.77(3.24) 26.25(4.5) 0Hemoglobin(g/dl) 11.07(1.025) 14.20(1.49) 0Total cholesterol(mg/
dl)151.74(30.9) 168.5(40.29) 0.09Systolic BP
(at the time of PCI)
mmHg154.4(26.03) 158.26(29.04) 0.001Patients with CKD were found to be older, lesser BMI and more
anemic at the time of PCI than Non-CKD patients, with signiﬁcant
p values. Dyslipidemia is not found to be signiﬁcantly different be-
tween the two study groups. Vascular complications were seen in 28
out of 380 patients with CKD and 17 out of 571 patients without CKD.
Patients with CKD were found to have higher risk of vascular com-
plications post PCI [p ¼0.02, OR¼2.592 (95% CI 1.346-5.026), RR¼2.475
(1.327-4.667)].
CONCLUSION Our study showed that CKD is a signiﬁcant risk factor
for vascular complications post-PCI compared to those without CKD.
So, eGFR calculations and precautions to avoid vascular complications
especially with newer antiplatelet regimen may be required.
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BACKGROUND Recent trial had been demonstrated that troponin T
elevation after percutaneous coronary intervention (PCI) was highly
related peri-procedural myocardial damage, which was well-known
predictor of major adverse cardiovascular event (MACE). However,
relationship between value of troponin I (TnI) after PCI and incidence
of MACE was not evaluated yet. The purpose of this study was to
assess the relationship between the value of TnI about twelve-hours
after PCI and incidence of short-term (6 months) MACE.
METHODS This was a retrospective analysis from prospective single
center registry. Between August 2013 to October 2014, 1,045 PCI for
patient with stable angina were performed at Heart Disease Center of
Miyazaki Medical Association Hospital. Of them, 726 cases were could
be measured TnI value after PCI, and were enrolled this retrospective
study. TnI was measured at the next morning after intervention
(about 12-hours after PCI), and upper limit of normal value (ULN) of
TnI was deﬁned as 0.035 ng/ml. Those patients were divided into four
groups, depending on their TnI levels; Negative (n¼316), ULNx5
(n¼87), ULNx10 (n¼127), and ULNx20 (n¼196). Primary outcome
measure of this retrospective study was Incidence of short term
(6-months) MACE in each group. Deﬁnition of MACE was a composite
outcome; all cause of death, Myocardial infarction, target lesion
revascularization and re-hospitalization due to angina or heart failure.
Cerebrovascular event and hemorrhagic event were excluded from
MACE.
RESULTS There were no signiﬁcant differences about lesion back-
grounds in each group. There was not relationship between lesion
severalty and TnI values (See Table 1). Table 2 showed incidence of
MACE at six month. There were signiﬁcant differences about inci-
dence of MACE in each groups (p¼0.00016). The higher value of TnI,
the more often adverse events were observed during six months
follow-up.
